Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H26N8O5 |
Molecular Weight | 494.5031 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2N=C(NC(=O)C3=CN=C(N)N=C3)N4CCN=C4C2=CC=C1OCCCN5CCOCC5=O
InChI
InChIKey=MRKMXPSMJSHTCR-UHFFFAOYSA-N
InChI=1S/C23H26N8O5/c1-34-19-16(36-9-2-6-30-8-10-35-13-17(30)32)4-3-15-18(19)28-23(31-7-5-25-20(15)31)29-21(33)14-11-26-22(24)27-12-14/h3-4,11-12H,2,5-10,13H2,1H3,(H2,24,26,27)(H,28,29,33)
Molecular Formula | C23H26N8O5 |
Molecular Weight | 494.5031 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:21:04 GMT 2023
by
admin
on
Sat Dec 16 14:21:04 GMT 2023
|
Record UNII |
UD5QDA5GMW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
UD5QDA5GMW
Created by
admin on Sat Dec 16 14:21:04 GMT 2023 , Edited by admin on Sat Dec 16 14:21:04 GMT 2023
|
PRIMARY | |||
|
2132943-79-2
Created by
admin on Sat Dec 16 14:21:04 GMT 2023 , Edited by admin on Sat Dec 16 14:21:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
(OXIDATION BY CYP3A4), The six healthy male volunteers received a single i.v. infusion of 12 mg copanlisib (2.76 MBq (14C)copanlisib) in a total volume of 40 mL as a 1-h infusion in the morning, 1-h after a light breakfast. 5 Caucasians and 1 Asian with an age 54.8 +/- 5.2 yeas (mean +/- SD, range: 47-61 years) and a BMI of 24.8 kg/m^2. Non-smokers and reported at the most light alcohol use.
AMOUNT EXCRETED
FECAL; PLASMA; URINE
|